PROSTEEZ TABLETS

Indications

• Skin conditions
• Wound healing
• Inflammatory skin disorders
• Respiratory ailments
• Gastrointestinal disorders

Dosage

Children: Specific dosing guidelines for pediatric use of asphaltum are not established. It is recommended to consult a healthcare provider for appropriate guidance.

Adults: Specific dosing guidelines for asphaltum are not established. It is typically used topically as needed for the treatment of skin conditions or as directed by a healthcare provider.

Mechanism of action

The exact mechanism of action of asphaltum is not fully understood, but it is thought to exert its effects through its anti-inflammatory properties, which may involve the inhibition of pro-inflammatory cytokines and the promotion of wound healing. It may also have a role in forming a protective barrier over wounds and affected areas, reducing the risk of infection.

Pharmacodynamics

Asphaltum demonstrates various pharmacological effects, including anti-inflammatory and antimicrobial activities. Its application can lead to improved healing in skin conditions by providing a protective layer and reducing inflammation. The exact pharmacodynamic profile can vary based on the formulation and method of application.

Pharmacokinetics

The pharmacokinetics of asphaltum are not well-characterized due to its topical usage and variable formulations. When applied topically, absorption through the skin may occur, although systemic absorption is generally minimal. The clearance and metabolism of asphaltum when used in this manner are not well-documented.

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal disturbances

Precautions

• Use with caution in individuals with skin sensitivities
• Avoid contact with eyes and mucous membranes
• Not recommended for use in open wounds or broken skin

Pregnancy

Safety during pregnancy has not been established, use with caution.

Breast-feeding

Safety during breastfeeding has not been established, use with caution.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Topical ointment
• Pastes
• Creams

Indications

• Fever
• Diarrhea
• Skin diseases
• Inflammation
• Pain relief

Dosage

Children: Refer to healthcare providers for appropriate dosing in children, as specific pediatric dosages are not established.

Adults: Refer to specific formulations and consult a healthcare professional for appropriate dosing guidelines, as there is no standardized dosage for Bauhinia.

Mechanism of action

The specific mechanism of action for Bauhinia is not well-defined in scientific literature. However, it is believed that the active compounds, particularly flavonoids, exert antioxidant effects, modulate inflammatory pathways, and may inhibit certain enzymes involved in inflammation and pain signaling. The presence of tannins may also contribute to anti-diarrheal effects by acting on the gastrointestinal tract.

Pharmacodynamics

Bauhinia extracts exhibit various pharmacological effects, including anti-inflammatory, analgesic, and antipyretic properties. The modulation of inflammatory mediators may help reduce symptoms associated with conditions like arthritis or muscle pain. The antioxidant activity can protect cells from oxidative stress, which is linked to various chronic diseases. Additionally, some species may exhibit antimicrobial properties, contributing to their traditional use in treating infections.

Pharmacokinetics

The pharmacokinetics of Bauhinia, including absorption, distribution, metabolism, and excretion, are not well-characterized in clinical studies. Generally, phytochemicals in plant extracts are absorbed through the gastrointestinal tract, but the bioavailability can vary significantly based on the formulation and the presence of other compounds. The metabolism often involves phase I and phase II reactions in the liver, and elimination may occur through urine or feces, depending on the specific compounds involved.

Pregnancy

Safety during pregnancy has not been established; consult healthcare professionals before use.

Breast-feeding

Unknown if excreted in human milk; caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Respiratory disorders
• Digestive issues
• Skin diseases
• Anemia
• General health and wellness

Dosage

Children: Paediatric dosing of bhasma is also variable and should be determined based on the child's age, weight, and specific health concerns. Consultation with a healthcare professional experienced in Ayurvedic medicine is advised.

Adults: Dosage for adults can vary widely based on the specific type of bhasma and the condition being treated. It is recommended to refer to traditional Ayurvedic guidelines or consult a qualified practitioner for specific dosing.

Mechanism of action

The exact mechanism of action of bhasma is not fully understood, but it is believed to involve the bioactive compounds released during the calcination process, which may exert antioxidant, anti-inflammatory, and immunomodulatory effects. These properties can enhance physiological functions and promote the healing processes in the body.

Pharmacodynamics

Bhasma exhibits various pharmacological effects, which may include modulation of immune responses, enhancement of metabolic functions, and promotion of detoxification processes. The bioavailability of minerals and metals in bhasma can lead to improved physiological activity, potentially affecting enzymatic activities and cellular signaling pathways.

Pharmacokinetics

Pharmacokinetic data specific to bhasma is limited due to its complex composition and traditional preparation methods. However, it is generally thought to be absorbed through the gastrointestinal tract when ingested, with its effects being dose-dependent. The elimination and metabolism of the components may vary based on individual physiology and the specific formulation of bhasma used.

Pregnancy

The safety of bhasma during pregnancy has not been well studied. It is advisable to consult a healthcare professional before use.

Breast-feeding

The excretion of bhasma in breast milk is not well documented. Caution is advised, and consultation with a healthcare professional is recommended.

Storage

Bhasma should be stored in a cool, dry place, away from direct sunlight and moisture, to maintain its potency and effectiveness.

Indications

• Respiratory tract infections
• Digestive disorders
• Urinary tract infections
• Anti-inflammatory applications
• Antimicrobial support

Dosage

Children: Refer to established herbal guidelines as no specific dosing information is available.

Adults: Refer to established herbal guidelines as no specific dosing information is available.

Mechanism of action

Cubeba contains various bioactive compounds, including essential oils, which have been shown to exhibit antimicrobial activity. The mechanism of action is thought to involve the disruption of microbial cell membranes and interference with metabolic processes, leading to cell death. Additionally, cubeba may exert anti-inflammatory effects by modulating the expression of pro-inflammatory cytokines.

Pharmacodynamics

Cubeba exhibits a range of pharmacological activities, including antimicrobial, anti-inflammatory, and analgesic properties. Its essential oil is rich in compounds such as cubebene and other terpenes, which contribute to its effects. Studies have indicated that cubeba may help alleviate respiratory conditions and improve digestive health, although more clinical research is needed to fully establish these effects.

Pharmacokinetics

The pharmacokinetics of cubeba, including its absorption, distribution, metabolism, and excretion, have not been extensively studied. However, it is presumed that the active constituents are absorbed through the gastrointestinal tract when consumed. The metabolism likely occurs via the liver, with elimination primarily through urine. Specific half-life and bioavailability data are not well-documented.

Pregnancy

There is insufficient reliable information regarding the safety of cubeba during pregnancy. It is advisable to avoid use unless benefits outweigh risks.

Breast-feeding

Limited data is available on the safety of cubeba during breastfeeding. Caution is recommended, and it should be avoided if possible.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Dosage

Children: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Adults: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Mechanism of action

The mechanism of action for purified compounds varies widely depending on the specific substance. Generally, purified drugs exert their effects by interacting with specific biological targets, such as receptors, enzymes, or ion channels, leading to a desired therapeutic effect. This interaction can involve binding to receptors to activate or inhibit signaling pathways, modulating enzymatic activity, or altering physiological processes.

Pharmacodynamics

Pharmacodynamics describes the effects of a drug on the body and the relationship between drug concentration and effect. For purified drugs, this can involve dose-response relationships and the time course of their action. The purified form often enhances potency and reduces variability in response among patients, which can lead to more predictable therapeutic outcomes. The overall effect is determined by the drug's affinity for its target, the efficacy of the drug-receptor interaction, and the downstream signaling pathways activated as a result of this interaction.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of a drug. For purified substances, absorption can be more efficient due to the absence of impurities that may affect solubility or stability. Distribution may also be enhanced, leading to higher bioavailability. Metabolism can be influenced by the structure of the purified compound, as it may be metabolized more readily by liver enzymes. Excretion typically occurs through the kidneys or liver, depending on the molecular characteristics of the purified drug.

Pregnancy

Consult with a healthcare professional, as the safety of purified forms of medications during pregnancy may vary depending on the specific substance.

Breast-feeding

Consult with a healthcare professional, as the safety of purified forms of medications during breastfeeding may vary depending on the specific substance.

Storage

Store in a cool, dry place, away from light and moisture, and keep out of reach of children.

Indications

• Parkinson's disease
• Restless legs syndrome

Dosage

Children: Refer to specific prescribing guidelines and product information for paediatric dosing.

Adults: Refer to specific prescribing guidelines and product information for adult dosing.

Mechanism of action

Repens acts as a selective agonist at dopamine D2 and D3 receptors, mimicking the action of dopamine. This action is particularly beneficial in conditions where dopamine levels are insufficient, such as in Parkinson's disease.

Pharmacodynamics

The activation of D2 and D3 dopamine receptors by repens leads to improved motor function and reduction of symptoms in patients with Parkinson's disease. It also influences the motor pathways in the brain, contributing to its efficacy in managing symptoms of restless legs syndrome.

Pharmacokinetics

Repens is well absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 1 to 2 hours after oral administration. It undergoes extensive hepatic metabolism, primarily via the cytochrome P450 system, and has a half-life of approximately 6 hours. Renal excretion accounts for a minor portion of the drug's elimination.

Pregnancy

Safety in pregnancy has not been established. Use only if potential benefit justifies potential risk to the fetus.

Breast-feeding

Use with caution. It is not known if this drug is excreted in human milk.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

Indications

• Benign prostatic hyperplasia (BPH)
• Urinary symptoms associated with BPH
• Supportive treatment for lower urinary tract symptoms

Dosage

Adults: Refer to the specific product guidelines, as dosages can vary. Commonly, doses range from 160 mg to 320 mg of standardized extracts per day, taken in divided doses.

Mechanism of action

The mechanism of action of serenoa involves the inhibition of 5-alpha-reductase, an enzyme that converts testosterone to dihydrotestosterone (DHT), which plays a critical role in the development of BPH. By reducing DHT levels, serenoa helps alleviate symptoms associated with prostate enlargement, such as urinary frequency and urgency. Additionally, it may have anti-inflammatory properties and can inhibit the action of prostaglandins that contribute to prostate swelling.

Pharmacodynamics

Pharmacodynamically, serenoa exhibits anti-androgenic effects due to its ability to modulate testosterone metabolism. This action leads to a decrease in prostate size and improvement in urinary flow. The onset of action may vary among individuals, and while some patients report symptom improvement within weeks, others may take longer to experience benefits. It is generally well-tolerated, with a low incidence of side effects compared to conventional pharmacological treatments for BPH.

Pharmacokinetics

Serenoa is typically administered orally and is absorbed in the gastrointestinal tract. Its bioavailability can be affected by food intake, with higher absorption rates noted when taken with meals. The active constituents are thought to be fatty acids and phytosterols, which contribute to its therapeutic effects. Metabolism occurs primarily in the liver, and the excretion of metabolites is mainly through the urine. The half-life of serenoa is not well-established, and clinical variability may affect its pharmacokinetic profile.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Constipation
• Headache
• Dizziness

Interactions

• May interact with anticoagulants and antiplatelet drugs, increasing the risk of bleeding
• May affect the metabolism of certain medications processed by the liver

Precautions

• Use with caution in patients with hormone-sensitive conditions
• Monitor for potential side effects in patients taking other medications

Pregnancy

Not enough reliable information available, use only if potential benefit justifies the risk.

Breast-feeding

Limited data available, consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Softgel capsules
• Liquid extract
• Tablets

Indications

• Constipation
• Digestive disorders
• Detoxification
• Antioxidant support
• Immune enhancement

Dosage

Children: For children, it is advisable to consult a healthcare professional for appropriate dosing recommendations, as specific pediatric doses may vary based on age and condition.

Adults: General guidance suggests starting with 1-2 teaspoons of triphala powder mixed in warm water, taken once or twice daily. For specific dosing, refer to established guidelines.

Mechanism of action

The mechanism of action of triphala is attributed to its rich polyphenolic content, vitamins, and minerals. It exhibits antioxidant activity by scavenging free radicals, thus reducing oxidative stress. Additionally, triphala has been shown to modulate gut microbiota, improve digestion, and promote regular bowel movements by enhancing peristalsis. It may also possess anti-inflammatory properties that contribute to its therapeutic effects.

Pharmacodynamics

Triphala demonstrates a variety of pharmacodynamic effects. Its components exhibit laxative properties, which help alleviate constipation. Amla is known for its high vitamin C content and immune-boosting effects, while haritaki is recognized for its digestive and detoxifying properties. The combined action of these fruits provides a synergistic effect, enhancing gastrointestinal function and supporting overall health.

Pharmacokinetics

The pharmacokinetics of triphala have not been extensively studied in clinical settings. However, it is generally believed that the absorption and bioavailability of its active constituents occur in the gastrointestinal tract. The metabolites exert their effects locally within the gut, while some components may enter systemic circulation, contributing to their antioxidant and anti-inflammatory activities. The elimination pathway is primarily through the gastrointestinal tract.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Abdominal cramping
• Nausea

Interactions

• May enhance the effects of anticoagulants
• May affect the absorption of other medications due to its laxative effects

Precautions

• Use with caution in patients with gastrointestinal disorders
• Patients on anticoagulant therapy should consult a healthcare provider before use

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extract

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Pregnancy

There is limited information on the use of variegata during pregnancy. It is advisable to avoid its use unless the benefits outweigh the risks.

Breast-feeding

The safety of variegata during breastfeeding is not well established. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Zinc deficiency
• Copper deficiency
• Immune system support
• Wound healing
• Skin health support

Dosage

Children: Refer to specific guidelines for paediatric dosing, as it is essential to consider age, weight, and clinical condition.

Adults: Refer to specific guidelines for dosage, as it may vary based on the condition being treated and individual patient factors.

Mechanism of action

Zinc acts as a cofactor for numerous enzymes and plays a vital role in cellular processes such as DNA synthesis, protein synthesis, and cell division. Copper is involved in the formation of hemoglobin and collagen, and it also helps in the absorption of iron. Together, they contribute to various biochemical pathways that support immune function and overall health.

Pharmacodynamics

The pharmacodynamics of Yashad is characterized by its role in enhancing immune function, promoting skin integrity, and facilitating wound healing. Zinc is known to modulate the immune response by supporting the activity of T-lymphocytes and influencing cytokine production. Copper contributes to antioxidant defense and is essential for maintaining normal physiological functions.

Pharmacokinetics

Zinc and copper are absorbed in the gastrointestinal tract, with factors such as dietary intake and the presence of other minerals influencing absorption rates. Once absorbed, zinc is distributed throughout the body, primarily in skeletal muscle and bone, while copper is distributed in liver, brain, and kidney tissues. Both minerals are excreted primarily through urine, with zinc also lost in feces.

Pregnancy

The safety of Yashad during pregnancy has not been established. It is recommended to be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Yashad is excreted in breast milk, and caution should be exercised when administered to a nursing mother.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.